Ken Griffin’s Achieve Life Sciences ACHV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$55.9K Buy
24,718
+18,495
+297% +$41.8K ﹤0.01% 5437
2025
Q1
$16.6K Sell
6,223
-25,512
-80% -$68.1K ﹤0.01% 5625
2024
Q4
$112K Buy
31,735
+31,729
+528,817% +$112K ﹤0.01% 5133
2024
Q3
$28 Buy
+6
New +$28 ﹤0.01% 5704
2024
Q2
Hold
0
5825
2024
Q1
Hold
0
6045
2023
Q4
Sell
-6,787
Closed -$29.2K 5822
2023
Q3
$29.2K Sell
6,787
-7,902
-54% -$34K ﹤0.01% 5226
2023
Q2
$76.2K Buy
14,689
+12,196
+489% +$63.3K ﹤0.01% 4853
2023
Q1
$17K Sell
2,493
-48,253
-95% -$328K ﹤0.01% 5424
2022
Q4
$125K Buy
50,746
+15,746
+45% +$38.9K ﹤0.01% 4917
2022
Q3
$116K Buy
35,000
+21,725
+164% +$72K ﹤0.01% 5056
2022
Q2
$65K Buy
+13,275
New +$65K ﹤0.01% 5431
2022
Q1
Sell
-19,207
Closed -$149K 6264
2021
Q4
$149K Buy
+19,207
New +$149K ﹤0.01% 5662
2021
Q2
Sell
-12,456
Closed -$144K 6348
2021
Q1
$144K Buy
+12,456
New +$144K ﹤0.01% 5635
2020
Q2
Sell
-7,011
Closed -$46K 4580
2020
Q1
$46K Buy
+7,011
New +$46K ﹤0.01% 4553
2019
Q3
Sell
-718
Closed -$28K 4618
2019
Q2
$28K Sell
718
-113
-14% -$4.41K ﹤0.01% 4457
2019
Q1
$54K Buy
+831
New +$54K ﹤0.01% 4212
2018
Q4
Sell
-1,329
Closed -$84K 4449
2018
Q3
$84K Buy
+1,329
New +$84K ﹤0.01% 3934
2017
Q4
Sell
-55
Closed -$22K 3825
2017
Q3
$22K Buy
55
+27
+96% +$10.8K ﹤0.01% 3502
2017
Q2
$22K Buy
28
+18
+180% +$14.1K ﹤0.01% 3492
2017
Q1
$9K Sell
10
-4
-29% -$3.6K ﹤0.01% 3592
2016
Q4
$15K Buy
+14
New +$15K ﹤0.01% 3489
2016
Q1
Sell
-11
Closed -$29K 3280
2015
Q4
$29K Buy
+11
New +$29K ﹤0.01% 3539
2015
Q2
Sell
-16
Closed -$75K 3766
2015
Q1
$75K Buy
+16
New +$75K ﹤0.01% 3314